Vicore Pharma Holding AB (VCRE) Stock Analysis & Investment Frameworks
Vicore Pharma Holding AB (VCRE) stock analysis on Invetso. Review Vicore Pharma Holding AB’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Vicore Pharma Holding AB Company Overview
- Exchange: NASDAQ
- Sector: Healthcare
- Industry: Biotechnology
- Country: SE
Vicore Pharma Holding AB Key Financial Metrics
- Market Cap: $291.52M
- Revenue: $385402.49
- ROE: -53.71%
- ROIC: -61.26%
- Dividend Yield: N/A
About Vicore Pharma Holding AB
Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.